Oncologists more likely to provide low-value care after receiving pharma money, study finds; Europe takes steps to head off drug shortages, even as U.S. proposals stall

Taking stock of the drug industry, from the lab to the medicine chest

October 26, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Oncologists more likely to provide low-value care after receiving pharma money, study finds The findings from a new study raise questions about the extent to which industry influence may have led to patient harm. By Ed Silverman STAT+ | Europe takes steps to head off drug shortages, even as U.S. proposals stall New regulations to combat drug shortages include incentives for manufacturing in Europe and a common strategic approach to stockpiling. By John Wilkerson STAT+ | Under-the-skin injection of Eisai's Leqembi is as effective as IV infusion, new Alzheimer's data show If the under-the-skin formulation of the Alzheimer's drug secures approval, self-injections, twice per week, could be done at home. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser